Enrolling Studies at STAT Research

Enrolling Studies

Below is the list of studies which are currently open for enrollment to those who qualify.

Study Name	Indication	Description	Location	Stipend	Apply
Abbvie M16-852	Giant Cell Arteritis	A Study to Evaluate the Safety and Efficacy of Upadacitinib in Participants With Giant Cell Arteritis	Vandalia, Ohio	$1900	Apply
PA0011	Psoriatic Arthritis	A MULTICENTER, PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY EVALUATING THE EFFICACY AND SAFETY OF BIMEKIZUMAB IN THE TREATMENT OF SUBJECTS WITH ACTIVE PSORIATIC ARTHRITIS	Vandalia, Ohio	$440	Apply
CA41705	Lupus Nephritis	A PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF OBINUTUZUMAB IN PATIENTS WITH ISN/RPS 2003 CLASS III OR IV LUPUS NEPHRITIS	Vandalia, Ohio	$1892	Apply
ACTIV-2	COVID-19	Adaptive Platform Treatment Trial for Outpatients with COVID-19 (Adapt Out COVID)	Springboro, Ohio	$730	Apply
PSA-013	Psoriatic Arthritis	Efficacy, Safety, and Tolerability Study of Apremilast to Treat Early Oligoarticular Psoriatic Arthritis.	Springboro, Ohio	$500	Apply

Upcoming Studies

Here is a list of the studies which we are not currently enrolling but expect to begin soon...

We currently do not have an upcoming studies to report.

How long do studies typically remain open for enrollment?

Studies typically have an enrollment period of about 6-months to a year. Of course, some studies enrollment windows are much shorter or longer depending on the enrollment criteria.

How many patients get enrolled on a study?

Most studies we conduct are multi-center studies, meaning there are many sites enrolling the same study across the country or globally. At STAT Research, we typically have enrollment numbers between 1 to 10 per study.